|Day Low/High||180.11 / 183.05|
|52 Wk Low/High||155.83 / 239.87|
The forces that benefited shares of companies such as Peloton Interactive and Clorox may not sustain them once the impact of the virus subsides.
There is a point where if longer-dated yields move high enough, defensive-minded investors will be drawn from equities to debt securities.
Let's review the charts and indicators.
With few exceptions, there isn't a stock that could bring down this market.
We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.
There will be a semi-permanent increase in demand for what businesses like Clorox provide.
SWKS reports Q4 earnings results after Monday's market close.
The worst case for the markets and the nation would be an election that's decided in the courts.
Some of the companies I'll be watching next week as the number of corporate reports tops 1,400 vs. roughly 1,100 this week. For the Stocks Under $10 portfolio we have ADT Inc. and Coty on tap, but I'll also be paying attention to what Alarm.com ha...
On a down day like this, you might want to bail. But instead of submitting to your emotions, aim your cash at these stocks.
If you want to clean up, then look at the hygiene trend -- and these numbers from Reckitt Benckiser and Procter & Gamble.
Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.
Beware of high-flying stocks and instead opt for these 'grounded' ones.
These big names are not smoke and mirrors, if you look at what they really do.
Both Apple and Tesla are chopping shares into pieces, which will let individual investors have a shot at buying them.
Blame the Fed? No. I'm reserving my wrath for the clueless buyers who appear to have taken a permanent intellectual summer vacation.
The whole group has run and the guidance from Clorox does show, more than anything, that nobody knows.
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.
In this market, winning stocks 'stick out like a sore thumb.'
This is how you can tell which camp is winning and which is losing in this time of Covid-contradiction.
How did it feel for traders who sold Facebook on news of the ad boycott? Like putting your hand on a hot stove.